搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
2 小时
Rangers once-vaunted power play has gone missing in growing concern
Since Chris Kreider has missed the past two games with back spasms, Alexis Lafreniere has filled in for the longest-tenured ...
19 小时
Blue Jackets’ Dean Evason infuriated by non-call in overtime loss: ‘It’s ridiculous!’
The Blue Jackets forced overtime against the Canadiens, but fell just 44 seconds into overtime after a play that set Evason ...
centralwinews
1 天
Medford board looks at next step after referendum
With voters approving a $22.6 million referendum earlier this month, the Medford school district will be moving into a ...
inc42
1 天
Honda Enters EV Segment With The Launch Of Two Escooters
After much ado, Honda Motorcycle & Scooter India (HMSI) has finally forayed into the EV segment with the launch of Activa E ...
TopSpeed
1 天
10 Closest Competitors To The Tesla Model Y
Few EVs can match the Tesla Model Y in price, performance, and efficiency, but we found 10 whose unique set of attributes ...
1 天
Lawmakers hit the gas on bill to prevent Mass. truck drivers from losing their licenses
On Tuesday, lawmakers on Beacon Hill took up a plan to help hundreds of truck and bus drivers across the state at risk of ...
2 天
F1 supports GM/Cadillac as an 11th team for the 2026 season
The F1 application process still has additional steps to complete, but F1's agreement in principle with General Motors is a ...
2 天
Wild ride: How Formula One approved GM's Cadillac entry for 2026
The 11th team will be called Cadillac F1 and be run by new Andretti Global majority owners Dan Towriss and Mark Walter.
Radio Ink
3 天
NASCAR Radio Pro Brad Gillie Promoted to PRN Lead Anchor
The Performance Racing Network has announced that Brad Gillie will be lead anchor alongside Mark Garrow starting with the 2025 NASCAR season.
FierceBiotech
3 天
Biohaven fails phase 3 SMA test but plans talks with FDA, plots move into obesity
A phase 3 trial of Biohaven’s taldefgrobep alfa in spinal muscular atrophy (SMA) has missed its primary endpoint. The biotech ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈